What is Claudio Lavareda Santos email address?

Claudio Lavareda Santos's primary email address is *******@praxismedicines.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Claudio Lavareda Santos work for?

Claudio Lavareda Santos is a SVP, Head of Global Medical Affairs at Praxis Precision Medicines, Inc., a company specializing in Commercial physical research.

Where Claudio Lavareda Santos graduated from?

Claudio Lavareda Santos holds a degree in from FIA Business School.

How can I directly contact Claudio Lavareda Santos?

To contact Claudio Lavareda Santos directly, you can use the email address *******@praxismedicines.com. Complete contact information is available upon registration with Muraena.

Is Claudio Lavareda Santos an immigrant?

Yes, Claudio Lavareda Santos is an immigrant and currently based in United States

Who is Claudio Lavareda Santos?

Claudio Lavareda Santos is a seasoned Senior Global Medical Affairs Leader with over 25 years of experience in the biopharmaceutical industry, specializing in rare diseases. With a strong background in medical affairs and business leadership, he has held executive roles in various multinational organizations, including Praxis Precision Medicines and Ptc Therapeutics. Claudio is known for his analytical skills and ability to synthesize complex data, which he uses to drive strategic medical initiatives and ensure high-quality outcomes. His leadership style is characterized by integrity, supportiveness, and a commitment to employee development, fostering a culture of collaboration and growth. Claudio's extensive experience spans multiple therapeutic areas, including neurology, oncology, and dermatology, and he has a proven track record of successful product launches and market access strategies. Fluent in both English and Portuguese, he effectively communicates with diverse stakeholders across different regions. Outside of his professional endeavors, Claudio is dedicated to continuous improvement and staying updated with emerging trends in the biopharmaceutical field.